000 01114 a2200325 4500
005 20250513120409.0
264 0 _c19970609
008 199706s 0 0 eng d
022 _a0140-6736
024 7 _a10.1016/s0140-6736(97)90016-7
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aScott, A M
245 0 0 _aClinical promise of tumour immunology.
_h[electronic resource]
260 _bLancet (London, England)
_cMay 1997
300 _aSII19-22 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAnimals
650 0 4 _aAntibodies, Monoclonal
_xtherapeutic use
650 0 4 _aAntibodies, Neoplasm
_ximmunology
650 0 4 _aAntigens, Neoplasm
_ximmunology
650 0 4 _aCancer Vaccines
_ximmunology
650 0 4 _aHumans
650 0 4 _aMelanoma
_xtherapy
650 0 4 _aNeoplasms
_ximmunology
650 0 4 _aNeoplasms, Experimental
_ximmunology
650 0 4 _aVaccination
700 1 _aCebon, J
773 0 _tLancet (London, England)
_gvol. 349 Suppl 2
_gp. SII19-22
856 4 0 _uhttps://doi.org/10.1016/s0140-6736(97)90016-7
_zAvailable from publisher's website
999 _c9145649
_d9145649